Constantine S. Tam, Sarah Kamel. Comment on Lipsky et al.: Incidence and Risk Factors of Bleeding-Related Adverse Events in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib. haematol [Internet]. 2016Feb.29 [cited 2025Jan.22];101(3):e123-e123. Available from: https://haematologica.org/article/view/7664